Arbutus Biopharma Corporation (ABUS) Gained 7.77% or 0.4 To Price $5.55 On Tuesday


Arbutus Biopharma Corporation (ABUS) gained 7.77% or 0.4 to $5.55. It is about 317269 shares traded, which is 129.89% compare to the average total volume 244269. The market cap of ABUS is $308.31 million. The year to date change is -5.5%. The 52 week price range is from $2.35 to $8.25. Price of ABUS have changed 1.98% during last week. It have changed 7.29% over last month, -17.60% over last 3 months, 37.33% over last 6 months and 101.96% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for ABUS is 5.31. It is -4.32% below current price. The 200-day Moving Averages for ABUS is 4.58. It is -17.48% below current price. The 52-week High is 8.25. It is 48.65% from the current price. The 52-week Low is 2.35. It is -57.66% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of ABUS is 2.74 on 2017-12-29. Short % to float is 1.50%. There are some statistics of ABUS. It is has market cap $308.31 million. The share outstanding is 55.55 million. The average volume is 244269. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of ABUS is -91.50%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of ABUS is -70.82%.


Tags:

Share this post